HERPES VIRUSES - Complete Notes
1. Classification of Herpes Viruses
Herpesviruses are large, enveloped, double-stranded DNA viruses. Classified into 3 subfamilies:
| Subfamily | Virus | Common Name |
|---|
| Alphaherpesvirinae | HSV-1 (HHV-1) | Herpes simplex 1 |
| HSV-2 (HHV-2) | Herpes simplex 2 |
| VZV (HHV-3) | Varicella-zoster virus |
| Betaherpesvirinae | CMV (HHV-5) | Cytomegalovirus |
| HHV-6A, HHV-6B | Roseola (6B causes disease) |
| HHV-7 | Roseola (minor cause) |
| Gammaherpesvirinae | EBV (HHV-4) | Epstein-Barr virus |
| KSHV (HHV-8) | Kaposi sarcoma herpesvirus |
Key shared properties:
- dsDNA, icosahedral capsid, enveloped
- Establish lifelong latency after primary infection
- Can reactivate (symptomatic or asymptomatic)
- All produce intranuclear inclusion bodies (Cowdry type A)
- All alphaherpesviruses are neurotropic (latency in sensory ganglia)
2. Infections Caused by HSV-1 and HSV-2
Incubation period: 2-14 days. Both serotypes are clinically indistinguishable.
HSV-1 (orofacial predominance):
- Herpes labialis - "cold sores"; vesicles at vermillion border; reactivation from trigeminal ganglion
- Primary herpetic gingivostomatitis - erythematous bleeding gums, painful vesicles throughout oral cavity
- Herpetic keratoconjunctivitis - dendritic corneal ulcers; ophthalmic emergency
- Herpes encephalitis - most common cause of sporadic fatal encephalitis; temporal lobe involvement
- Eczema herpeticum - life-threatening vesicular eruption on pre-existing eczema skin; treat with IV acyclovir
- Herpetic whitlow - infection of distal finger by autoinoculation
HSV-2 (genital predominance):
- Genital herpes - painful vesicles/ulcers on genitalia; frequent recurrences
- Neonatal herpes - acquired during vaginal delivery; can be disseminated, CNS, or skin/eye/mouth (SEM) type
- Herpes meningitis - recurrent benign lymphocytic meningitis (Mollaret's)
- Sacral radiculopathy - urinary retention, constipation
Both types cause:
- Asymptomatic viral shedding (major source of transmission)
- Disseminated disease in immunocompromised/neonates
- Latency in sensory ganglia (trigeminal for HSV-1, sacral for HSV-2)
3. Lab Diagnosis of HSV Infections
| Method | Details |
|---|
| Tzanck smear | Scrape base of vesicle; Giemsa stain; shows multinucleated giant cells with intranuclear inclusions; does NOT distinguish HSV from VZV |
| Viral culture | Gold standard for active lesions; CPE visible in 24-48 hours; HSV spreads rapidly |
| PCR | Most sensitive and specific; method of choice for CSF (encephalitis), atypical cases |
| DFA (Direct Fluorescent Antibody) | Rapid; fluorescent-labeled antibodies on vesicle scrapings; distinguishes HSV-1 from HSV-2 |
| Type-specific serology (ELISA) | gG-1 antibody = HSV-1; gG-2 antibody = HSV-2; useful for epidemiology, not acute diagnosis |
| Histopathology | Cowdry type A intranuclear inclusions; multinucleated giant cells |
- For herpes encephalitis: CSF PCR is the method of choice
- For ocular herpes: Slit lamp + fluorescein staining shows dendritic ulcers
4. Pathogenesis of Chickenpox (Varicella)
Step-by-step:
- Entry - VZV inhaled; infects mucosal cells of upper respiratory tract/conjunctiva
- Primary viremia - Replication in regional lymph nodes → enters bloodstream
- Visceral replication - Virus replicates in liver and spleen
- Secondary viremia - Infected mononuclear cells transport virus to skin and respiratory mucosa
- Rash formation - Swelling of epithelial cells, ballooning degeneration, tissue fluid accumulation → vesicle formation
- Immune response - Humoral + cellular immunity + interferon terminate infection
- Latency - Virus establishes latency in trigeminal and dorsal root ganglia
- Reactivation - If immunity wanes → herpes zoster (shingles)
Incubation period: 10-21 days
Rash: Successive crops - macules → papules → vesicles → crusts; ALL stages present simultaneously; starts on trunk, spreads centrifugally; palms/soles spared; "dewdrop on rose petal" appearance
Complications: Pneumonia (most common in adults/immunocompromised), encephalitis, hepatitis, Reye syndrome (with aspirin), bacterial superinfection (Staph/Strep)
5. Neonatal Varicella / Congenital Varicella
Neonatal Varicella:
- Mother develops chickenpox 5 days before to 2 days after delivery
- Infant receives no protective maternal IgG (insufficient time for transplacental transfer)
- Leads to severe, disseminated disease - pneumonia, hepatitis, DIC; can be fatal
- Management: VariZIG to neonate immediately; IV acyclovir if disease develops
Congenital Varicella Syndrome (CVS):
- Mother infected during 1st-2nd trimester (highest risk: weeks 8-20)
- Risk of CVS: approximately 2% of primary infections in first 20 weeks
Features of CVS:
- Skin: cicatricial (zigzag) scarring in dermatomal distribution
- Limb: hypoplasia, atrophy
- Eye: chorioretinitis, cataracts, microphthalmia
- CNS: microcephaly, cortical atrophy, mental retardation, seizures
- IUGR (intrauterine growth retardation)
6. Ramsay Hunt Syndrome
Definition: Reactivation of VZV in the geniculate ganglion of CN VII
Classic Triad:
- Otalgia - severe pain in and around the ear
- Herpetic vesicles - on the pinna, external auditory canal (herpes zoster oticus)
- Peripheral facial palsy - lower motor neuron facial nerve palsy (resembles Bell's palsy)
Additional features:
- SNHL, tinnitus, and vestibular symptoms in up to 50% of patients
- Cranial nerves V, IX, X, XI, XII may also be affected
- Incidence: ~30 per 100,000 persons
Pathophysiology: VZV reactivates in geniculate ganglion → inflammation of sensory + motor cranial nerves → facial palsy + ear vesicles + pain
Diagnosis: Clinical; confirm by VZV PCR from vesicular fluid or MRI (enhancement along intratemporal facial nerve)
Treatment: Oral corticosteroids + oral antivirals (acyclovir/valacyclovir); combination therapy recommended
7. Lab Diagnosis of Chickenpox (VZV)
| Method | Details |
|---|
| Clinical diagnosis | Usually sufficient; characteristic rash (multiple stages simultaneously, centrifugal spread) |
| Tzanck smear | Multinucleated giant cells; does NOT distinguish VZV from HSV |
| DFA | More specific; detects VZV antigen in vesicle scrapings; distinguishes from HSV |
| PCR | Most sensitive and specific; method of choice for immunocompromised, atypical cases, CSF |
| Viral culture | Technically difficult; VZV is cell-associated, spreads slowly; rarely performed |
| FAMA test | Fluorescent Antibody to Membrane Antigen; gold standard for detecting VZV immunity (past infection or vaccine response) |
| ELISA / complement fixation | Rising antibody titers confirm infection; useful for immunity screening |
8. Immunoprophylaxis of Chickenpox
Active immunization:
- Live attenuated varicella vaccine (Oka strain): Approved 1995; 2 doses (12-15 months + 4-6 years); also available as MMRV
- Zoster vaccine - Shingrix (recombinant subunit): Adults ≥50 years; 2 doses 2-6 months apart; highly effective against shingles and postherpetic neuralgia
- Zoster vaccine - Zostavax (live attenuated): Adults ≥60 years; being phased out in favour of Shingrix
Passive immunization:
- VariZIG (Varicella-Zoster Immune Globulin): Post-exposure prophylaxis for high-risk seronegative individuals; given within 10 days of exposure; modifies but may not prevent infection
- Standard IVIG: Low VZV antibody titer; generally not effective for VZV prophylaxis
High-risk groups requiring VariZIG:
- Immunocompromised seronegative patients
- Seronegative pregnant women
- Neonates of mothers with perinatal varicella
- Premature infants <28 weeks
9. Infections Caused by Cytomegalovirus (CMV)
CMV (HHV-5) has the largest genome of all human herpesviruses (240 kbp). Key pathology: "owl eye" intranuclear inclusions in massively enlarged (cytomegalic) cells.
In immunocompetent hosts:
- Usually asymptomatic
- CMV mononucleosis - heterophil-negative mono; fever, malaise, fatigue, mild hepatitis; self-limited; accounts for 20-50% of heterophil-negative mono cases
In immunocompromised hosts (transplant, AIDS):
- CMV retinitis - "pizza pie" fundus; leading cause of blindness in AIDS (CD4 <50)
- CMV pneumonitis - interstitial pneumonia; most common in bone marrow transplant recipients
- CMV colitis - bloody diarrhea, abdominal pain
- CMV hepatitis, encephalitis
- Post-transplant complications: leukopenia, obliterative bronchiolitis (lung Tx), graft atherosclerosis (heart Tx)
Congenital CMV (most common congenital viral infection):
- ~1% of live births in USA; ~5-10% of those develop severe disease
- Features: microcephaly, periventricular calcifications, IUGR, jaundice, hepatosplenomegaly, thrombocytopenic purpura ("blueberry muffin baby"), chorioretinitis, SNHL
- Mortality ~20%; survivors: mental retardation, deafness, ocular defects
- Even subclinical congenital CMV → deafness in ~10%
Treatment: Ganciclovir / valganciclovir (first-line); foscarnet, cidofovir (resistance/toxicity)
10. Infections Caused by Epstein-Barr Virus (EBV)
EBV (HHV-4) infects B lymphocytes via CD21 receptor (CR2, the C3d complement receptor). Establishes latency in B cells.
Infectious Mononucleosis ("kissing disease" / "mono"):
- Incubation: 30-50 days
- Transmission: oropharyngeal secretions (saliva)
- Classic triad: Fever + Exudative pharyngitis + Lymphadenopathy (especially posterior cervical)
- Splenomegaly (50-60%), hepatitis, maculopapular rash (especially with ampicillin/amoxicillin)
- Atypical lymphocytes (Downey cells) on blood smear - large reactive T cells
- Heterophil antibodies (agglutinate sheep/horse RBCs) - detected by Monospot test
- Self-limited: 2-4 weeks
- Complications: splenic rupture, airway obstruction, hemolytic anemia, thrombocytopenia
EBV-associated malignancies:
- Burkitt lymphoma - B cell lymphoma; jaw tumor in African children; >90% contain EBV DNA; t(8;14) c-myc translocation; malaria = cofactor
- Nasopharyngeal carcinoma - epithelial cancer; common in Chinese/Southeast Asian males; EBNA1 + LMP1 expressed
- Hodgkin's lymphoma (mixed cellularity subtype)
- Post-transplant lymphoproliferative disorder (PTLD)
- Non-Hodgkin lymphoma in AIDS
Lab diagnosis:
- Monospot test (heterophil agglutination)
- EBV serology:
- VCA-IgM = current/acute infection
- VCA-IgG = past infection (persists for life)
- EA (early antigen) antibodies = active viral replication
- EBNA antibodies = appear weeks after acute infection, persist for life (absence = recent primary infection)
11. Roseola Infantum (Exanthem Subitum)
Causative agent: Primarily HHV-6B; less commonly HHV-7
Alternative name: Exanthem subitum = "sudden rash"
Age group: Infants and children 6 months to 4 years
Clinical course:
| Phase | Duration | Features |
|---|
| Febrile phase | 3-5 days | Abrupt high fever (39-40°C); irritable; febrile convulsions possible; leukopenia |
| Defervescence | Sudden | Fever drops abruptly |
| Rash phase | 24-48 hours | Faint macular/maculopapular rash on trunk → spreads outward; disappears in 1-3 days |
Key point: Rash appears as fever resolves - this pattern is pathognomonic
Features:
- Child appears relatively well despite high fever
- Febrile seizures are a recognized complication
- Leukopenia during febrile phase
- Virus establishes latency in monocytes/macrophages and salivary glands
Treatment: None specific; symptomatic only (antipyretics, hydration); self-limited
Sources: Jawetz Melnick & Adelberg's Medical Microbiology 28th Ed | Tintinalli's Emergency Medicine | Cummings Otolaryngology | Sherris & Ryan's Medical Microbiology 8th Ed